Home/ Supplements/ Alpha Lipoic Acid
Compound

Alpha Lipoic Acid

Also known as ala, alpha lipoic acid, alpha-lipoic acid, lipoic acid

21 Research sources
90/100 Market safety
200.0 mg Median dose
502 Products on market

Key takeaways

  • ALA is effective in treating symptomatic diabetic peripheral neuropathy (PMID: 22837391, 32370731).
  • ALA supplementation improves glycemic control and lipid profiles in patients with metabolic diseases (PMID: 29990473).
  • ALA may influence iron homeostasis (PMID: 40134249).
Evidence

What the research shows

AI-synthesized from 21 peer-reviewed sources · Updated 2025

Alpha-Lipoic Acid (ALA) is a potent antioxidant used primarily for the management of diabetic complications. Research indicates it is most effective in reducing neuropathic pain and improving glycemic control in patients with diabetes.

By condition

Diabetic Peripheral Neuropathy Strong
Multiple meta-analyses and RCTs demonstrate ALA's efficacy in reducing neuropathic pain and improving symptoms of diabetic neuropathy.

Glycemic Control/Metabolic Disease Moderate
Evidence suggests ALA can improve glucose control and lipid profiles in patients with metabolic diseases and obesity.

Non-Alcoholic Fatty Liver Disease (NAFLD) Weak
Preliminary RCT evidence suggests ALA, when combined with other supplements, may improve metabolic profiles and liver function in obese patients.

Athletic Performance Insufficient
Research indicates ALA fails to improve anaerobic or aerobic performance in trained cyclists despite reducing blood lactate.

Effective doses

300 mg to 600 mg (administered orally or i.v.)

Safety & interactions

Generally well-tolerated; however, users should monitor for potential interactions with glucose-lowering medications due to its effect on glycemic control.

Limitations

Some studies rely on small sample sizes (e.g., N=11 or N=36) and often use ALA as part of a multi-ingredient cocktail, making it difficult to isolate the specific effect of ALA alone.

Products

Top-rated Alpha Lipoic Acid products

Ranked by safety score and evidence coverage

View all 502 products →
Marketplace

How it's sold

Data aggregated from 502 product labels

Forms
Top brands
Claims vs evidence
75% Evidence-backed
87% Structure/function
25% Unsupported
Sources

Research evidence

Showing top 10 of 21 sources, sorted by quality

Systematic Review· The Cochrane database of systematic reviews· 2024· n=816· PMID 38205823

BACKGROUND: Diabetic peripheral neuropathy (DPN) is a frequent complication in people living with type 1 or type 2 diabetes. There is currently no effective treatment for DPN. Although alpha-lipoic acid (ALA, also known as thioctic acid) is…

Rct· Nutrients· 2024· n=36· PMID 39339645

AIM: To investigate the efficacy of Palmitoylethanolamide (PEA, 300 mg), Superoxide Dismutase (SOD, 70 UI), Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg), nicotinamide (9 mg), and minerals (Mg…

Meta Analysis· International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition· 2024· n=529· PMID 40134249

**Sharifi-Zahabi et al., 2024** | Int J Vitam Nutr Res | Meta Analysis Sharifi-Zahabi Elham, Abdollahzad Hadi. Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Control…

Meta Analysis· Medicine· 2023· PMID 37933068

BACKGROUND: This systematic review explores the most current evidence regarding the mechanisms of neuropathic pain in patients with different types of diabetes and how this pain affects different functional and structural components of the …

Meta Analysis· Metabolism: clinical and experimental· 2018· PMID 29990473

OBJECTIVE: This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to summarize the effect of alpha-lipoic acid (ALA) supplementation on glycemic control and lipid profiles among patients with metabolic…

Meta Analysis· European journal of endocrinology· 2012· PMID 22837391

OBJECTIVE: To evaluate the effects and safety of 300-600 mg α-lipoic acid (ALA) given i.v. for diabetic peripheral neuropathy (DPN). METHODS: We searched the databases of Medline, Embase, and Cochrane central register of Controlled Trials a…

Rct· Endocrine, metabolic & immune disorders drug targets· 2020· n=100· PMID 32370731

BACKGROUND: Alpha-lipoic acid (ALA) was used in the treatment of diabetic peripheral neuropathy (DPN) using different routes, doses and treatment durations. The aim of this work is to assess the efficacy of oral 600mg ALA twice daily over 6…

Rct· Journal of postgraduate medicine· 2024· PMID 39641383

BACKGROUND: Diabetic peripheral neuropathy (DPN) is a chronic microvascular complication in diabetic mellitus patients due to chronic hyperglycemia, resulting in platelet hyperactivity and dyslipidemia. Alpha-lipoic acid (ALA) is a potent a…

Systematic Review· Canadian journal of diabetes· 2024· n=11· PMID 38295879

OBJECTIVES: Current medications for diabetic neuropathy (DN) recommended by the American Diabetes Association and American Academy of Neurology do not address the pathologic process of denervation among patients with DN, because ancillary t…

Rct· Pakistan journal of pharmaceutical sciences· PMID 39340853

To investigate the effect of tanshinone IIA sulfonate sodium combined with α-Lipoic acid on fasting blood sugar (FPG), 2h postprandial blood glucose (2hPG), total cholesterol (TG), triacylglycerol (TC) and therapeutic effect in patients wit…

FAQ

Frequently asked questions

What is Alpha-Lipoic Acid and what is it used for?

Alpha-Lipoic Acid (ALA) is a potent antioxidant primarily used for managing diabetic complications. Research indicates it is most effective in reducing neuropathic pain and improving glycemic control in patients with diabetes.

Does Alpha-Lipoic Acid work for diabetic neuropathy?

Yes, there is strong evidence that ALA is effective in treating symptomatic diabetic peripheral neuropathy. Multiple meta-analyses and randomized controlled trials demonstrate its efficacy in reducing neuropathic pain and improving symptoms.

Can Alpha-Lipoic Acid help with blood sugar control?

There is moderate evidence suggesting ALA can improve glucose control and lipid profiles in patients with metabolic diseases and obesity. However, because it affects glycemic control, users should monitor their blood sugar levels closely.

What is the effective dose of Alpha-Lipoic Acid?

The effective doses for ALA range from 300 mg to 600 mg. These doses can be administered either orally or intravenously, depending on the specific medical guidance provided.

Is Alpha-Lipoic Acid safe to take?

ALA is generally well-tolerated, but it may influence iron homeostasis and interact with glucose-lowering medications. Pregnant individuals, those on diabetes medication, or people with liver conditions should consult a healthcare provider before use to avoid potential risks.

Does Alpha-Lipoic Acid improve athletic performance?

Research is insufficient to support claims that ALA improves athletic performance. Studies indicate it fails to enhance anaerobic or aerobic performance in trained cyclists, despite its ability to reduce blood lactate.

Can Alpha-Lipoic Acid help with fatty liver disease?

Evidence for this use is weak, with only preliminary RCTs suggesting potential benefits when combined with other supplements. Research is limited regarding its standalone efficacy for Non-Alcoholic Fatty Liver Disease (NAFLD), so consulting a doctor is recommended.